Daaco, Irine Kate .
HRN: 15-39-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
OXACILLIN 500MG (VIAL)
08/09/2022
08/08/2022
IVT
160
Q6
CELLULITIS Left Leg And Thigh
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes